Page last updated: 2024-12-07

2,5-diketogluconate

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

2,5-diketogluconate: RN given refers to calcium salt [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2,5-didehydro-D-gluconate : Conjugate base of 2,5-didehydro-D-gluconic acid. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID9548631
CHEBI ID11449
MeSH IDM0176151

Synonyms (9)

Synonym
2,5-diketogluconate
d-threo-hexo-2,5-diulosonate
d-threo-2,5-hexodiulosonate
2,5-diketo-d-gluconate
CHEBI:11449 ,
2,5-didehydro-d-gluconate
(3s,4s)-3,4,6-trihydroxy-2,5-dioxohexanoate
Q27089388
DTXSID301344278
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
2-oxo monocarboxylic acid anionAn oxo monocarboxylic acid anion in which the oxo group is located at the 2-position.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (2)

PathwayProteinsCompounds
Ketogluconate Metabolism1017
L-ascorbate biosynthesis VI (engineered pathway)416
ketogluconate metabolism712

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (9.09)18.7374
1990's1 (9.09)18.2507
2000's4 (36.36)29.6817
2010's5 (45.45)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]